首页> 外文期刊>The Journal of laboratory and clinical medicine >Platelet adhesion onto artificial surfaces: inhibition by benzamidine, pentamidine, and pyridoxal-5-phosphate as demonstrated by flow cytometric quantification of platelet adhesion to microspheres.
【24h】

Platelet adhesion onto artificial surfaces: inhibition by benzamidine, pentamidine, and pyridoxal-5-phosphate as demonstrated by flow cytometric quantification of platelet adhesion to microspheres.

机译:血小板粘附在人造表面上:苯甲idine,喷他idine和5-磷酸吡x醛的抑制作用,如血小板对微球粘附的流式细胞术定量所证实。

获取原文
获取原文并翻译 | 示例
           

摘要

An appreciable effort is directed toward designing strategies to minimize platelet interactions with artificial surfaces, because their reactivity is thought to promote thrombus formation and lead to materials failure. Although platelet glycoprotein Ib/IX (GPIb/IX) and glycoprotein IIb/IIa (GPIIb/IIIa) receptors are thought to mediate adhesion, whether GPIIb/IIIa receptors are activated and how this might occur are largely unknown and are the focus of this article. There are a few ways, other than thrombin generation, that blood contact with artificial surfaces can lead to GPIIb/IIIa activation. Complement activation can lead to products capable of activating platelets (C1q, C5b-9), and contact between platelet CD32 (FcgammaRII) receptors and immobilized immunoglobulin G could also activate platelets. In this article the potential role of these processes was evaluated by using various inhibitors in a microsphere-based platelet adhesion immunoassay. Polystyrene microspheres (10 microm) were incubated in platelet-rich plasma before flow cytometric analysis of beads for adherent platelets. The data eliminated occupancy of the FcgammaRII receptor (by use of IV.3 blocking antibody), C5b-9 production (by use of sCR1), and the indirect action of factor XIIa on complement components (by use of corn trypsin inhibitor) as playing roles in supporting platelet adhesion. Agents directed against the first complement component (benzamidine, pentamidine, pyridoxal-5-phosphate) were effective inhibitors of platelet adhesion and were also demonstrated to inhibit SC5b-9 and C3d levels on the bead surface after serum incubations. Because these agents are not highly specific, it can not be concluded that C1q is a mediator of adhesion. These agents were also demonstrated to inhibit fluorescein isothiocyanate-fibrinogen binding to activated washed platelets, therefore indicating that fibrinogen receptor expression is a requirement for platelet adhesion.
机译:由于可以认为血小板的反应性会促进血栓的形成并导致材料的破坏,因此在设计策略上要尽量减少血小板与人造表面的相互作用。尽管人们认为血小板糖蛋白Ib / IX(GPIb / IX)和糖蛋白IIb / IIa(GPIIb / IIIa)受体介导粘附,但GPIIb / IIIa受体是否被激活以及如何发生仍是未知的,这是本文的重点。除了凝血酶的产生外,还有几种方法可以使血液与人造表面接触会导致GPIIb / IIIa活化。补体激活可导致能够激活血小板的产物(C1q,C5b-9),而血小板CD32(FcgammaRII)受体与固定的免疫球蛋白G之间的接触也可激活血小板。在本文中,通过在基于微球的血小板粘附免疫测定中使用各种抑制剂来评估这些过程的潜在作用。在富血小板血浆中孵育聚苯乙烯微球(10微米),然后对珠进行流式细胞术分析粘附的血小板。数据消除了FcgammaRII受体的占用(通过使用IV.3封闭抗体),C5b-9的产生(通过使用sCR1)以及因子XIIa对补体成分的间接作用(通过使用玉米胰蛋白酶抑制剂)在支持血小板粘附中的作用。针对第一个补体成分(苯甲m,喷他,、吡ido醛-5-磷酸)的药剂是血小板粘附的有效抑制剂,并且在血清培养后也被证明可以抑制珠子表面的SC5b-9和C3d水平。因为这些试剂不是高度特异性的,所以不能断定C1q是粘附的介质。还证明了这些试剂可抑制荧光素异硫氰酸酯-纤维蛋白原与活化的洗涤过的血小板结合,因此表明纤维蛋白原受体的表达是血小板粘附的必要条件。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号